We are live on ! Find out more
IART icon

Integra LifeSciences
IART

257 hedge funds and large institutions have $5.09B invested in Integra LifeSciences in 2021 Q1 according to their latest regulatory filings, with 35 funds opening new positions, 68 increasing their positions, 104 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

35% more first-time investments, than exits

New positions opened: 35 | Existing positions closed: 26

6% more capital invested

Capital invested by funds: $4.8B → $5.09B (+$285M)

2% more funds holding

Funds holding: 251 → 257 (+6)

4% more call options, than puts

Call options by funds: $12.4M | Put options by funds: $11.9M

0.46% less ownership

Funds ownership: 87.97% → 87.5% (-0.46%)

33% less funds holding in top 10

Funds holding in top 10: 3 → 2 (-1)

35% less repeat investments, than reductions

Existing positions increased: 68 | Existing positions reduced: 104

Holders
257
Holders Change
+6
Holders Change %
+2.39%
% of All Funds
4.51%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.04%
New
35
Increased
68
Reduced
104
Closed
26
Calls
$12.4M
Puts
$11.9M
Net Calls
+$477K
Net Calls Change
+$2M

Top Buyers

Rank Fund Capital Flow
1
EVM
Eaton Vance Management
Massachusetts
+$16.6M
2
Goldman Sachs
Goldman Sachs
New York
+$16.2M
3
Millennium Management
Millennium Management
New York
+$14.4M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$9M
5
BlackRock
BlackRock
New York
+$7.72M

Top Sellers

Rank Fund Capital Flow
1
Capital International Investors
Capital International Investors
California
-$12.5M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$11.5M
3
KCM
Kennedy Capital Management
Missouri
-$7.86M
4
TCM
Tributary Capital Management
Nebraska
-$7.53M
5
Invesco
Invesco
Georgia
-$6.78M
Name Holding Trade Value Shares
Change 		Change in
Stake
HI
226
Harbour Investments
Wisconsin
$10K +$9.48K +140 New
AIG
227
American International Group
New York
$8.87K +$47.4K +699 +0.5%
CAGAS
228
Capital Advisory Group Advisory Services
Minnesota
$8K – – –
S
229
SignatureFD
Georgia
$8K – – –
ST
230
Smithfield Trust
Pennsylvania
$8K – – –
CT
231
Caldwell Trust
Florida
$6.91K +$6.78K +100 New
FRA
232
Front Row Advisors
California
$6K – – –
GAM
233
Gemmer Asset Management
California
$6K – – –
MWP
234
Meridian Wealth Partners
Pennsylvania
$6K +$5.62K +83 New
BWM
235
BerganKDV Wealth Management
Minnesota
$5K – – –
TWA
236
TCI Wealth Advisors
Arizona
$5K – – –
HR
237
Howe & Rusling
New York
$4K -$1.02K -15 -20%
FGAM
238
Financial Gravity Asset Management
Texas
$3.21K +$3.12K +46 New
CFA
239
Carroll Financial Associates
North Carolina
$3K – – –
Carson Wealth (CWM LLC)
240
Carson Wealth (CWM LLC)
Nebraska
$3K – – –
FPS
241
Fieldpoint Private Securities
Connecticut
$3K – – –
PA
242
Parallel Advisors
California
$3K – – –
WAP
243
Wealthcare Advisory Partners
Pennsylvania
$3K +$3.05K +45 New
GFPC
244
Global Financial Private Client
Florida
$2.59K – – –
ACM
245
Allred Capital Management
Texas
$2.49K +$2.44K +36 New
HPC
246
HM Payson & Co
Maine
$2K – – –
PMFA
247
Plante Moran Financial Advisors
Michigan
$2K – – –
PFBT
248
Parkside Financial Bank & Trust
Missouri
$2K +$1.15K +17 +189%
Jones Financial Companies
249
Jones Financial Companies
Missouri
$2K +$1.63K +24 New
Nisa Investment Advisors
250
Nisa Investment Advisors
Missouri
$1.85K -$4.56M -67,270 -72%
8 9
10
11 12

IART Hedge Fund Activity: Q1 2021 in Review

257 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Integra LifeSciences (IART) for Q1 2021, worth a combined $5.09B — up 5.9% from $4.8B a quarter earlier.

Buyers outnumbered sellers: 35 funds opened new IART positions and 26 closed out — a net gain of 9 holders — while 68 added to existing stakes and 104 trimmed.

The largest buyer was Eaton Vance Management, adding an estimated $16.6M. The largest seller was Capital International Investors, exiting entirely with an estimated $12.5M sold.

  • 257 institutional investors held Integra LifeSciences (IART) as of Q1 2021, up from 251 in Q4 2020.
  • Funds reported $5.09B of Integra LifeSciences stock for Q1 2021, up 5.9% quarter-over-quarter.
  • 35 funds opened new Integra LifeSciences positions in Q1 2021 and 26 closed out, a net change of +9 holders.
  • The largest Integra LifeSciences buyer in Q1 2021 was Eaton Vance Management, an estimated $16.6M added.
  • The largest Integra LifeSciences seller in Q1 2021 was Capital International Investors, an estimated $12.5M sold.

Based on aggregated 13F filings for Q1 2021.